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Abstract
Nrf2 is a key transcription factor that regulates cellular redox and defense responses. However, permanent Nrf2 activation in
human lung carcinomas promotes pulmonary malignancy and chemoresistance. We tested the hypothesis that Nrf2 has cell
survival properties and lack of Nrf2 suppresses chemically-induced pulmonary neoplasia by treating Nrf2
+/+ and Nrf2
-/- mice
with urethane. Airway inflammation and injury were assessed by bronchoalveolar lavage analyses and histopathology, and
lung tumors were analyzed by gross and histologic analysis. We used transcriptomics to assess Nrf2-dependent changes in
pulmonary gene transcripts at multiple stages of neoplasia. Lung hyperpermeability, cell death and apoptosis, and
inflammatory cell infiltration were significantly higher in Nrf2
-/- mice compared to Nrf2
+/+ mice 9 and 11 wk after urethane.
Significantly fewer lung adenomas were found in Nrf2
-/- mice than in Nrf2
+/+ mice at 12 and 22 wk. Nrf2 modulated
expression of genes involved cell-cell signaling, glutathione metabolism and oxidative stress response, and immune
responses during early stage neoplasia. In lung tumors, Nrf2-altered genes had roles in transcriptional regulation of cell
cycle and proliferation, carcinogenesis, organismal injury and abnormalities, xenobiotic metabolism, and cell-cell signaling
genes. Collectively, Nrf2 deficiency decreased susceptibility to urethane-induced lung tumorigenesis in mice. Cell survival
properties of Nrf2 were supported, at least in part, by reduced early death of initiated cells and heightened advantage for
tumor cell expansion in Nrf2
+/+ mice relative to Nrf2
-/- mice. Our results were consistent with the concept that Nrf2 over-
activation is an adaptive response of cancer conferring resistance to anti-cancer drugs and promoting malignancy.
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Introduction
Lung cancer is the leading cause of cancer mortality worldwide,
thus creating an enormous public health burden [1]. Adenocar-
cinoma (AC), the predominant subtype of non-small cell lung
carcinoma (NSCLC), is the most prevalent NSCLC among
smokers and is the only lung cancer found in non-smokers [2].
Unfortunately due to the lack of useful biomarkers, AC is rarely
detectable until advanced stages of the disease, which makes it one
of the most clinically intractable of lung cancers [3].
In mice, urethane induces lung ACs and the time frame for
development of hyperplasias, adenomas, and ACs is well
characterized and accepted as a model for human lung AC
[4,5,6]. Histopathologically, murine ACs are indistinguishable
from human AC [4,7]. The progenitor cells for AC development
include type II pneumocytes and Clara cells [4,7]. ACs are
associated with mutations in Kras oncogene and tumor suppressor
genes such as Tp53 in humans and mice.
Nuclear factor, erythroid derived 2, like 2 (Nrf2), is a ubiquitous
key modulator of cellular defense against oxidative stress and
inflammation. Nrf2 binds to a cis-acting antioxidant response
element (ARE) to induce transcription of multiple cytoprotective
proteins including phase 2 detoxifying enzymes, drug efflux
pumps, and reactive oxygen species (ROS) scavengers [8].
Kelch-like ECH-associated protein 1 (Keap1) suppresses Nrf2 to
maintain homeostasis of Nrf2-ARE responsiveness by sequestering
and driving proteasomal degradation of cytoplasmic Nrf2 and by
shuttling nuclear Nrf2 to the cytoplasm. Stimuli which dissociate
Nrf2 from Keap1 to activate Nrf2 include pro-oxidants,
antioxidants, and chemopreventive agents. In multiple models of
pulmonary non-neoplastic inflammatory and oxidant diseases,
exacerbated injury, inflammation, and oxidant stress were found
in Nrf2 deficient mice (Nrf2
-/-) compared to wild type (Nrf2
+/+)
mice [8,9,10].
Importantly, recent studies have revealed that somatic muta-
tions in functional domains or epigenetic changes (methylation) in
CpG islands of KEAP1 which decrease KEAP1 function are
associated with increased risk of human lung neoplasia and
chemoresistance [11,12,13,14]. Further, siRNA silencing of NRF2
in these neoplastic cells inhibited their growth and recovered
chemotherapeutic sensitivity [13,15]. These studies suggested that
lung cancer cells with ’permanent’ NRF2-ARE activation due to
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26590weakened KEAP1 acquired multiple advantages for proliferation
and resistance to chemotherapy promoting malignancy. However,
molecular mechanisms explaining this potential advantage for
cancer cell growth have not been fully elucidated. In the current
study, we tested the hypothesis that Nrf2 has a cell survival role in
chemical-induced pulmonary neoplasia using Nrf2
+/+ and Nrf2
-/-
mice. Using bioinformatic tools for transcriptome analysis, we
defined potential downstream effector mechanisms of Nrf2-
directed lung tumorigenesis.
Results
Differential urethane sensitivity during pre-neoplastic
stage
Pulmonary injury. Microscopic analysis of bronchoalveolar
lavage (BAL) cells indicated pulmonary cytotoxicity including lysis
at 9–11 wk after initial urethane injection in Nrf2
-/- and Nrf2
+/+
mice. Increases in mean numbers of BAL epithelial cells and
leukocytes, as well as total protein concentration, were significantly
greater in Nrf2
-/- than Nrf2
+/+ mice after 9–11 wk (Figure 1-A). By
11 wk, BAL cell aggregation was mostly resolved in both strains,
but cell lysis remained in Nrf2
-/- mice with concurrent
manifestation of significantly higher large atypical macrophages
showing phagocytosis or necrosis-like features than in Nrf2
+/+ mice
(Figure 1A; Figure S1). Significantly greater membrane rupture
was also found in BAL cells from Nrf2
-/- mice than Nrf2
+/+ mice
(Figure S1). At 9 wk, BAL cell clustering accompanied cytolysis,
and this feature was markedly greater in Nrf2
-/- mice compared to
Nrf2
+/+ mice (Figure S1). This observation is assumed to be
associated with excess viscous secretion such as mucus as suggested
by aggregation of cells with secreted mucus in Alcian Blue
(pH 2.5)/periodic acid-Schiff (AB/PAS)-stained lungs (Figure S1),
or by procoagulant activity due to fibrin deposition in
mononuclear phagocytes which occurs during lung inflammation
[16,17]. Infiltrated neutrophils were obvious but not quantifiable
due to extensive clustering and lysis of BAL cells in Nrf2
-/- mice;
consistent with this observation, neutrophil myeloperoxidase
(MPO) activity was significantly higher in Nrf2
-/- mice than in
Nrf2
+/+ mice treated with urethane (Figure 1A). Urethane-induced
increase in lactate dehydrogenase (LDH) activity, a quantitative
indicator of necrotic cell lysis, was also significantly greater in BAL
returns from Nrf2
-/- compared to Nrf2
+/+ mice (Figure 1B).
Body weight (BW) changes. Urethane restrained BW gain
during the injection period (1–11 wk) in both genotypes relative to
saline injection (Figure 1C). However, a lower BW was observed in
Nrf2
-/- mice than in Nrf2
+/+ mice during the inflammatory period
from 7–11 wk (Figure 1C).
Differential responses in early neoplastic stage
Apoptosis and proliferation. Immunohistochemical
detection of proliferating cell nuclear antigen (PCNA, a cell
proliferation marker [18]) at 12 wk demonstrated that PCNA-
positive cells in G1/S phase were localized extensively in small
adenomas, focal alveolar hyperplastic lesions, injured perivascular
and peribronchial regions, and nodular lymphoid aggregates in
adventitia of blood vessels. Compared to Nrf2
-/-, more abundant
and intense localization of PCNA were found in small
adenomatous regions of Nrf2
+/+ mice (Figure 2A). PCNA was
sporadic in conducting airway epithelium of saline controls
(Figure 2A). Consistent with differential BAL cell necrosis at 9–
11 wk, the number of apoptotic lung cells determined by terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling
(TUNEL) in proximal pulmonary sections was more highly
elevated in Nrf2
-/- mice compared to Nrf2
+/+ mice at 12 wk
(Figure 2B). TUNEL-positive cells included epithelial, endothelial,
and smooth muscle cells. Few apoptotic cells were found in lungs
of vehicle control mice.
Early adenoma formation. Lung tumors were evident and
countable (.200 mm) from 12 wk following initiation of urethane
treatment. The numbers of sporadic adenomas were significantly
lower (2-fold) in Nrf2
-/- mice compared to Nrf2
+/+ mice (Figure 2C).
Differential tumorigenesis at 22 wk
Multiplicity (,43%) of small (#1.6 mm) adenomas was
significantly reduced in Nrf2
-/- mice compared to Nrf2
+/+ mice at
22 wk after urethane treatment (Figure 3A). However, no
differences were found in overall tumor size or tumor morphology
between genotypes. Large tumors were located primarily at the
lung pleural surface, while small developing tumors were more
frequent in internal regions. While no specific differences were
observed in other BAL phenotypes, the numbers of neutrophils
were significantly lower in Nrf2
-/- mice compared to Nrf2
+/+ mice
at 22 wk (Figure 3B).
Nrf2 activation in tumor-bearing lungs
Compared to saline controls at 22 wk, lung Nrf2 protein was
increased in tumor tissues and in remaining uninvolved lung
tissues (UN: adjacent, non-tumor bearing regions) of Nrf2
+/+ mice
(Figure 4A). Nuclear levels of Nrf2 (Figure 4A) and total ARE
binding activity of nuclear proteins (Figure 4B) were also higher in
tumor-bearing lungs. Specific binding activities of Nrf2 and its
dimerization partner small Maf on ARE were also heightened by
urethane (Figure 4B). Abundant Nrf2 was located throughout the
epithelium lining bronchial/bronchiolar and alveolar airways in
control mice (Figure 4Ca). At 22 wk after urethane, the Nrf2-
bearing cell populations were apparent in hyperplastic foci and
growing adenomas in addition to their increase in the airway
epithelium (Figure 4Cc).
Gene expression profiling during urethane-induced
tumorigenesis
Transcriptomics in early tumorigenesis of Nrf2
+/+ mice
(12 wks). To identify potential mechanisms of urethane-
induced tumorigenesis, we then used trancriptomics of tumor
and uninvolved tissue to identify differentiating gene networks.
Significant changes in 6519 lung gene transcripts were found in
Nrf2
+/+ mice relative to saline controls in 12 wk, and expression
changes were mostly 2-fold or lower (Table S1; n=3 mice/group).
Functional classification by Ingenuity Pathway Analysis (IPA)
determined that lung genes changed during early tumorigenesis
have roles in cellular growth and proliferation, cell and tissue
development, cell cycle and cellular assembly, small molecule
biochemistry, lipid metabolism, and molecular transport
(Figure 5A, top panel; Table S1).
Tumor gene expression profiles in Nrf2
+/+ mice
(22 wk). Among genes significantly changed over saline
controls at 22 wk in Nrf2
+/+ mice (8683 genes), 83% were
changed significantly only in tumors (Figure 5-B; n=3 mice/
group). Expression kinetic profiles of genes modulated in tumor
tissues (22 wk) were similar to their kinetics during early
tumorigenesis (12 wk) and in the microenvironment of tumors
(i.e., UN) at 22 wk (Figure 5B). Genes changed by urethane
(mostly #2-fold) in UN tissues played roles mainly in small
molecule biochemistry, immune cell trafficking, and cellular
movement (Figure 5A, middle panel). A small number of genes
(n=78) associated with signal transduction, transcriptional
regulation, ubiquitin-dependent protein catabolism, and muscle
contraction were changed in UN, but not in tumors at 22 wk.
Nrf2 Promotes Cell Survival in Lung Tumorigenesis
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the tumors included transmembrane protein 27 (Tmem27, 51-fold),
BCL12-like 15 (Bcl2l15, 48-fold), and claudin 2 (Cldn2, 43-fold). In
contrast, genes suppressed the most in the tumors included
carbonic anhydrase 3 (Car3, -92-fold), myosin light polypeptide 7,
regulatory (Myl7, -87-fold), troponin T2, cardiac (Tnnt2, -85-fold),
actin, alpha, cardiac muscle 1 (Actc1, -52-fold), and cytochrome
P450, family 2, subfamily a, polypeptide 4 (Cyp2a4, -36-fold). Also
changes in numerous families of gene clusters were evident, which
included ankyrin and ankyrin repeat domain, Rho GTPase
activating proteins, chemokine (C-C motif) or (C-X-C motif)
ligand and receptors, cell cycle protein families, C-type lectin
domain family, Cyp family, fibroblast growth factors and receptors,
gap junction protein (Gj) family, and G protein-coupled receptors.
Genes changed more than 2-fold in tumors (n=3461, up-
regulated 1233 and down-regulated 2228 genes) were associated
functionally in networks of genetic/skeletal and muscular/
developmental disorders, cellular and hematological system
development, hematopoiesis, cell cycle/growth, and cancer
(Figure S2; Table S2). Genes involved in cellular growth and
proliferation were modulated significantly by urethane regardless
of the times (12 and 22 wk) and tissues (UN, tumors) during
carcinogenesis, while genes associated with cancer (e.g., Bcl6, Peg3),
cellular movement (e.g., Prdx1, Cadm1), neurological disease (e.g.,
Cxcl1. Aff2), and inflammatory response (e.g., Itga4, Pla2g7) were
significantly changed in all the tissue types after tumor
Figure 1. Bronchoalveolar lavage analysis (BAL) and body weight changes at a pre-neoplastic stage. (A) BAL analysis found significantly
higher concentration of total protein and numbers of monocytes, lymphocytes, phagocytic macrophages, and epithelial cells in Nrf2
-/- mice at 9 and/
or 11 wk after urethane treatment. Neutrophilic myeloperoxidase (MPO) activity in BAL fluids was also significantly higher in Nrf2
-/- mice than in
Nrf2
+/+ mice. Mean6SD are presented (n=3/group for vehicle, n=529/group for urethane). *, p,0.05 vs. genotype-matched controls. +,p ,0.05 vs.
treatment-matched Nrf2
+/+ mice. (B) Necrotic lung cell lysis and death was assessed by lactate dehydrogenase (LDH) activity in aliquots of BAL fluids
using a colorimetric assay. Mean6SD are presented (n=3/group for vehicle, n=529/group for urethane). *, p,0.05 vs. genotype-matched controls.
+,p ,0.05 vs. treatment-matched Nrf2
+/+ mice. (C) Percent whole body weight changes monitored during and after saline or urethane treatment.
Mean6SD are presented (n=9224 in vehicle groups, n=64282 in urethane groups). *, p,0.05 Nrf2
+/+ saline-treated vs. urethane-treated mice
(p,0.05). #,p ,0.05 Nrf2
-/- saline-treated vs. urethane-treated mice. +,p ,0.05 urethane-treated Nrf2
+/+ mice vs. urethane-treated Nrf2
-/- mice
(p,0.05).
doi:10.1371/journal.pone.0026590.g001
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molecular biochemistry (oxidation, metabolism, and transport
reactions of acids, vitamins, and hormones) and lipid and nucleic
acid metabolisms (e.g., Cyp1a1, Slco1a5, Fabp1) and cell
morphology (e.g., Cdkn1a, Cxcl9) were modulated in common
during the early tumorigenesis stage (12 wk) and in UN tissues at
22 wk (Figure 5A) suggesting similar molecular events are taking
place in early neoplasia and in the tumor microenvironment.
Nrf2-dependent transcriptomics in early tumorigenesis
(12 wk). Because we found Nrf2-dependent differences in
tumorigenesis, we used trancriptomic profiling of tumors and
uninvolved tissues to identify gene networks that provide potential
mechanistic insight to Nrf2-mediated effects. Gene transcripts
(n=118) that were significantly different between Nrf2
+/+ and
Nrf2
-/- mice 12 wk after urethane treatment (Table 1; n=3 mice/
group) were categorized primarily in cell-to-cell signaling and
interaction, connective tissue development and function, cellular
movement, tissue/cell morphology and cellular development, and
inflammatory response and immune cell trafficking processes
(Figure 6A; Figure S3A). Expression profiles were classified into 4
cluster sets (Figure 6B, Dataset S1). Transcripts highly up-
regulated by urethane in Nrf2
-/- mice relative to Nrf2
+/+ mice
(set 0) included melanoma antigen (Mela), growth arrest specific 6
(Gas6), integrin alpha 6 (Itga6), matrix metalloproteinase 2 (Mmp2),
CD34 antigen (Cd34), D site albumin promoter binding protein
(Dbp), and transforming growth factor, beta induced (Tgfbi). Other
gene clusters (sets 1–3) that were relatively suppressed in Nrf2
-/-
mice compared to Nrf2
+/+ mice (Figure 6B, Table 1, Dataset S1)
included genes for ARE-responsive antioxidants, solute carrier
family, chemokines, arginase type II (Arg2), and attractin like 1
(Atrnl1).
Nrf2-dependent transcriptomics in tumors (22 wk). Ure-
thane caused Nrf2-dependent changes in a small number of the gene
transcripts (n=11) in the tumor microenvironment (UN) at 22 wk
relative to controls. Transcripts included polymerase, delta (Poldip2),
sonic hedgehog (Shh), and ribonuclease T2 (Rnaset2). IPA indicated that
tumor microenvironment participates in a network of cellular growth
and proliferation, tumor morphology, and cellular development
(Figure S3B; n=3 mice/group). A number of genes (n=376) were
significantly changed in tumor tissues relative to vehicle-treated tissues
Figure 2. Early stage tumorigenesis at 12 wk. (A) H&E-staining demonstrate pulmonary hyperplastic regions and early tumor development
(arrow heads) 12 wk after the first urethane injection. Greater tumor cell proliferation in sporadically small adenomatous regions was found in Nrf2
+/+
mice than Nrf2
-/- mice as indicated by denser proliferating cell nuclear antigen (PCNA) localization in relatively more advanced tumors (inset).
Representative light photomicrographs showing intermediate magnitude of pathology for each treatment group are presented (n=328/group for
H&E, n=3/group for PCNA). AV, alveoli; TB, terminal bronchiole; BV, blood vessel; UN, uninvolved region. Arrow heads, tumor; arrows, PCNA-positive
nuclei. Bars indicate 100 mm. (B) Numerous apoptotic airway cells in Nrf2
-/- mice were identified by TUNEL assay on paraffin-embedded lung tissue
sections. TUNEL-positive nuclei of epithelial, endothelial, and smooth muscle cells on proximal lung sections were counted and normalized to airway
surface (mm
2) using digital image processing software. Few TUNEL-stained cells were found in vehicle control mice. Mean6SD are presented (n=3/
group). +,p ,0.05 vs. urethane-treated Nrf2
+/+ mice. (C) Differential early tumor formation between Nrf2
+/+ and Nrf2
-/- mice. Average number of
tumors ($200 mm) per whole lung from each mouse was assessed in serial sections of paraffin-embedded lungs fixed with 10% NBF. Mean6SD are
presented (n=13214/group). +,p ,0.05 vs. urethane-treated Nrf2
+/+ mice.
doi:10.1371/journal.pone.0026590.g002
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largest family of genes encodes thiol metabolism enzymes (e.g.
glutathione-S-transferase family), solute carrier family members, and
transmembrane proteins. Predominant functional categories of Nrf2-
dependently changed tumor genes at 22 wk (Figure 6A, bottom panel)
were largely similar to those of Nrf2-dependent lung genes determined
at the 12 wk early neoplastic stage (Figure 6A, top panel). However,
Nrf2 effector genes in tumor tissue were more closely associated with
drug metabolism, cell cycle and death and organismal survival, and
tumor morphology (Figure 6A, Figure S3C). Canonical pathway
analysis by IPA determined that Nrf2 effector genes in lung tumors
overlaid multiple signal transduction mechanisms including predicted
glutathione metabolism (12 out of 98 pathway molecules match, 12/
98), oxidative stress response (14/183), aryl hydrocarbon receptor
signaling (12/154), LPS/IL-1 mediated inhibition of RXR function
(14/213), glioblastoma multiforme signaling (12/163), and others
(Dataset S3). Expression profiles of these 376 Nrf2-dependent tumor
transcripts were classified (Figure 6C, Dataset S2); subsets of tumor
genes that were relatively less-responsive to urethane (set 0) or more
suppressed (set 1) in Nrf2
-/- than in Nrf2
+/+ mice involved cell cycle,
antioxidant regulation, cell-cell interaction, and metabolism. Some
antioxidants and solute carrier family genes were differentially down-
regulated in tumors (set 2), while vasculature, immunity, and other
antioxidant genes were differentially up-regulated in tumors (set 3).
Although major functional categories of Nrf2-dependent transcripts
were similar in early neoplastic lungs and in tumors (see Figure 6B),
only 21 individual genes were found to be common at these two stages
(Figure 6D). Among them, Cd34, protein tyrosine phosphatase,
receptor type, F (Ptprf), Txnrd1, Pgd, Ugt1a1, Gpr137b, and dynein
light chain Tctex-type 1 (Dynlt1) were connected in a molecular
network of cancer-cell cycle-cell death (Figure S3C).
Validation of Nrf2-dependent transcripts identified at
early and late stages of carcinogenesis. Differential mRNA
expression of multiple ARE-responsive genes that were increased
(aldo-keto reductase family 1, member B8, Akr1b8; aldehyde
oxidase 3, Aox3; Prdx1) or decreased (aldehyde dehydrogenase 1
family, member A1, Aldh1a1; Gstm; glutathione peroxidase 2, Gpx2)
in tumors were confirmed using qRT-PCR (Figure S4A). Total
tissue glutathione (GSH) levels were also compared between the
two genotypes to support Nrf2-dependent changes of many genes
engaged in GSH synthesis mechanisms (e.g., glutathione
synthetase, Gss; Gclc; glucose-6-phosphate dehydrogenase X-
linked, G6pdx) after urethane treatment (Figure S4A). Non-
antioxidant genes with Nrf2-dependent expression patterns were
confirmed by qRT-PCR in 12 wk (Mela, Cd34, Areg, Itga6, Arg2,
Nek6) and in 22 wk (Cxcl1, Cks1b, Cdkn2c, Gjb1,Cd14, prostaglandin
I2 synthase, Ptgis), most of which were involved in the primary
functional networks identified using the pathway analysis tool
(Table 2, Figure S3).
Discussion
We have found that murine Nrf2 has a cell survival role in lung
cancer. That is, Nrf2 deficiency reduced sensitivity to urethane-
induced lung tumorigenesis. Importantly, Nrf2 deficiency signifi-
cantly enhanced lung inflammatory and cell injury responses
during early pre-neoplastic stages. Transcriptomic analysis of the
Nrf2-dependent gene transcript expression during early tumori-
genesis (12 wk after urethane) identified specific pathways
including cell-to-cell signaling and interaction, connective tissue
development and function, glutathione metabolism and oxidative
stress, and immune/inflammatory responses. Nrf2-dependent
gene expression in the late stages of tumorigenesis was associated
with cell cycle regulation, organismal injury/survival, xenobiotic/
thiol metabolism, and cell-to-cell signaling. Many similarities were
found in these functional categories between the early and late
phases of tumorigenesis, while immunological responses early and
cell cycle/growth and organismal survival in the more advanced
stages were unique. Results suggest that reductions of ARE-
responsive cytoprotective genes in tumor cells of Nrf2
-/- mice
render disadvantage to their survival during urethane-induced
tumorigenesis and that other, non-antioxidant/defense pathways
observed such as cell cycle and cell-to-cell signaling are essential
Figure 3. Adenoma development and persistent lung inflam-
mation at 22 wk. (A) Average number of adenomas per whole lung
from each animal (tumor multiplicity) and number of tumors per size
ranges and average size (mm) of individual tumors were assessed in
lungs fixed with Tellyesniczky’s fixative. Mean6SD are presented
(n=425/group saline; n=14/group for tumor multiplicity; n=14220/
group for tumor size). This study was repeated once with similar n and
responses determined. *, p,0.05 vs. genotype-matched controls.
+,p ,0.05 vs. urethane-treated Nrf2
+/+ mice. (B) Bronchoalveolar lavage
(BAL) analysis of the number of neutrophils in Nrf2
+/+ and Nrf2
-/- mice at
22 wk after urethane treatment. Mean6SD are presented (n=7210/
group urethane treated and n=325/group for saline). *, p,0.05 vs.
genotype-matched controls. +,p ,0.05 vs. urethane-treated Nrf2
+/+
mice.
doi:10.1371/journal.pone.0026590.g003
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findings support observations that activated Nrf2 is associated with
an increased risk of human lung cancer [13].
Our results deviated from other experimental tumorigenesis
models in non-pulmonary tissues (e.g., gallbladder, liver, stomach,
colon, esophagus, skin, head/neck, prostate, bladder, mammary)
where tumors or cancers were increased in Nrf2
-/- mice relative to
Nrf2
+/+ mice [19,20,21,22,23,24,25,26,27,28]. However, a recent
study found that experimentally implanted lung cancer cells (Lewis
lung carcinomas) produced significantly more pulmonary meta-
static nodules in Nrf2
-/- than in Nrf2
+/+mice, while the metastatic
nodule formation was suppressed in Keap1-knockdown mice
compared to Keap1 normal mice [29]. The authors suggested that
Nrf2 in host lung tissues prevents pulmonary metastasis through
Figure 4. Pulmonary Nrf2 expression and activation caused by urethane. (A) Western blot analysis of total Nrf2 protein in uninvolved (UN)
and tumor tissues compared to saline control in lung at 22 wk (57 kDa determined). Nuclear translocation of Nrf2 in urethane-treated lungs at 22 wk
was determined by Western blot analysis in whole lung nuclear extracts (10 mg). Lamin B1 level was determined as an internal control. (B) Binding
activity of nuclear protein (5 mg) to [c
32P]ATP end-labeled oligonucleotide probe containing ARE consensus sequence was determined. Gel shift
analysis demonstrated increased total ARE binding activity (arrows) of lung nuclear proteins after urethane treatment in Nrf2
+/+ mice. Supershifted
bands (arrow head) indicate specific binding activity of nuclear Nrf2 or small Maf on ARE determined by addition of anti-Nrf2 or –Maf (F/G/K)
antibodies to the reaction. Representative digitized bands of Western blotting and gel shift analysis (n=2/group) are presented. (C)
Immunohistochemistry for Nrf2 in saline- (a) or urethane-treated (c,e) tissue sections. Greater localization of Nrf2 proteins (brown dots) in growing
adenomas and in conducting airway and alveolar epithelial cells was found in Nrf2
+/+ mice. Nrf2 was located mainly in airway epithelial cells of vehicle
control lungs. Lung sections from Nrf2
-/- mice (e) are shown as a negative control for Nrf2. H&E-stained lower magnification of lung sections treated
with vehicle (b) or urethane (d,f) are depicted for general histology. Representative images showing intermediate degree of Nrf2 staining for each
treatment group are presented (n=3/group). AV=alveoli, BR=bronchi or bronchiole, TB=terminal bronchiole, BV=blood vessel, Bar=100 mm.
doi:10.1371/journal.pone.0026590.g004
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immune cells by increasing immunosuppressive cells which can
lead to a decrease in CD8
+ T-cell immunity. We also tested the
role of Nrf2 in a 2-stage tumorigenesis model using 3-
methylcholanthrene (3-MCA) as the initiator followed by butylat-
ed hydroxytoluene (BHT) as the promoter. Interestingly, no
differences in tumor multiplicity were found between Nrf2
-/- and
Nrf2
+/+ mice (data not shown), which suggested that the molecular
pathways required for urethane-induced tumorigenesis are
different from the 2-stage model. Given the potential role for
Nrf2 in protection from cytotoxicity during the urethane-induced
tumor initiation stage, it is possible that the cell survival or
beneficial nature of Nrf2 may depend on chemical carcinogens
and on the stages of carcinogenesis (i.e., initiation, promotion, or
metastasis) in mice. Therefore, assessment of other models,
specifically those bypassing inflammation and injury phase during
initiation or those focused on the advanced stages, well past tumor
promotion, may provide additional insight to the characteristics of
pulmonary Nrf2.
Promotion of cell survival is a phenotype that has been linked to
Nrf2. In embryonic fibroblasts and HepG2 cells, cell survival
involves adaptation to deal with the increased ROS called "an
adaptive survival response" and in some cases involves an Nrf2
effector, heme oxygenase-1 [30]. In the current study we found
that not only well-known ARE responsive genes (e.g., Prdx1, Ugt)
but other novel Nrf2-dependent redox genes such as Akr1b8,
NADPH oxidase organizer 1 (Noxo1), and solute carrier genes (e.g.,
Slc13a2) may have a role in cellular survival during lung
tumorigenesis. Recent studies determined that permanent or
constitutive NRF2 activation in human primary lung cancer cells
and lung cancer cell lines (e.g., A549, H460) with KEAP1 and/or
NRF2 somatic mutations was associated with enhanced chemore-
sistance and radioresistance, and siRNA inhibition of NRF2
restored the chemosensitivity of these cells [15,25,28,31]. Chemo-
resistance observed in these studies resulted from the overexpres-
sion of ARE-responsive genes encoding drug efflux pumps
including multidrug resistant–associated protein (Mrp). This
indicates that permanent NRF2 activation may be a novel
Figure 5. Lung gene expression profiles during urethane-induced tumorigenesis. (A) Urethane effects on gene expression during lung
tumorigenesis were compared by biological function and disorder categories of genes significantly changed in pre-/early-neoplastic stage at 12 wk
(top), in uninvolved tissues (UN) at 22 wk (middle), and in tumors at 22 wk (bottom) using Ingenuity Pathway Analysis (IPA). Top-ranked categories
are depicted against -log(p) determined by IPA. (B) Among the lung gene transcripts significantly (p,0.05) changed in uninvolved (UN, n=1564) and
tumor (n=8683) tissues compared to saline-treated lung tissues, Venn diagram analysis identified genes changed in either tissue or in common at
22 wk after the initial urethane treatment (top). Expression profiles of all tumor genes (n=8683, 22 wk UT-Tum) are depicted in pre-/early neoplastic
microenvironment (12 wk) and in UN tissues of tumor-bearing lungs at 22 wk (bottom). Color bar indicates expression intensity of individual
transcripts normalized to their time-matched saline control levels expressed in yellow (yellow to blue, down-regulation; yellow to red, up-regulation).
Y axis=log2 (normalized average intensity), Sal=saline-treated whole lung, UT=urethane-treated (whole lung for 12 wk, UN or Tum for 22 wk),
UN=uninvolved tissue, Tum=tumor tissue.
doi:10.1371/journal.pone.0026590.g005
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PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e26590Table 1. Representative lung genes from a total of 118 that were significantly (p,0.05) different between Nrf2
+/+ and Nrf2
-/- mice
12 wk after beginning urethane treatment.
GI Accession
Gene
Symbol Gene Description Major Gene Ontology (GO) Categories
Cluster
(Figure 7A)
Cell-To-Cell Signaling and Interaction, Connective Tissue Development and Function
NM_019521 Gas6 growth arrest specific 6 regulation of cell growth, calcium ion binding 0
NM_009369 Tgfbi transforming growth factor, beta induced cell adhesion 0
NM_008610 Mmp2 matrix metallopeptidase 2 blood vessel maturation, collagen catabolic process,
peptidoglycan metabolic process
0
NM_133654 Cd34* CD34 antigen cell adhesion, leukocyte migration 0
BM935811 Itga6 integrin alpha 6 cell adhesion, leukocyte migration 0
AI987929 Ndrg1 N-myc downstream regulated gene 1 cell differentiation, mast cell activation 1
BF168458 Timp2 tissue inhibitor of metalloproteinase 2 negative regulation of cell proliferation, regulation of
MAPKKK cascade
3
Glutathione metabolism, Nrf2-mediated oxidative Stress Response, Drug metabolism
NM_011034 Prdx1* peroxiredoxin 1 regulation of NF-kappa B import into nucleus, response to
oxidative stress
1
NM_010497 Idh1 isocitrate dehydrogenase 1 (NADP+), soluble glutathione metabolic process, response to oxidative stress,
glyoxylate cycle,
1
NM_015762 Txnrd1* thioredoxin reductase 1 cell proliferation, cell redox homeostasis 2
NM_009676 Aox1* aldehyde oxidase 1 electron transport 2
BC019434 Ugt1a2* UDP glucuronosyltransferase 1 family, polypeptide
A2
transferase activity 2
NM_008180 Gss glutathione synthetase glutathione biosynthetic process 2
BM210600 Srxn1 sulfiredoxin 1 homolog response to oxidative stress 3
NM_009656 Aldh2 aldehyde dehydrogenase 2 oxidation reduction, metabolic process 3
NM_181415 Atrnl1* attractin like 1 G-protein coupled receptor protein signaling 3
Organ Development, Gene expression, Cancer
BI247018 Ptpmt1 protein tyrosine phosphatase, mitochondrial 1 phosphatidylinositol metabolic process, protein amino acid
dephosphorylation
0
AW493043 Zfp346 zinc finger protein 346 apoptosis, double-stranded RNA binding 0
BG074964 Sra1 steroid receptor RNA activator 1 apoptosis, cell differentiation and proliferation 1
AF061972 Htatip2 HIV-1 tat interactive protein 2 angiogenesis, apoptosis, cell cycle 2
NM_016974 Dbp D site albumin promoter binding protein regulation of transcription, DNA-dependent, regulation of
cell proliferation
0
Immune responses
NM_020001 Clec4n C-type lectin domain family 4, member n proteolysis, macromolecule catabolic process, immune
response
2
NM_011355 Sfpi1 hematopoietic transcription factor PU.1, SFFV proviral
integration 1
granulocyte, lymphocyte, and macrophage differentiation 2
AF128196 Ccl9 chemokine (C-C motif) ligand 9 chemotaxis, immune response 3
NM_009140 Cxcl2 chemokine (C-X-C motif) ligand 2 chemotaxis, immune response 3
Cellular Compromise, Cellular Growth and Proliferation
BB188812 Ptpn5 protein tyrosine phosphatase, non-receptor type 5 protein amino acid dephosphorylation, phosphoric
monoester hydrolase activity
0
AK016670 Bcl2l14 BCL2-like 14 Apoptosis facilitator, regulation of cell death 1
Lipid catabolism
AK004768 Osbpl3 oxysterol binding protein-like 3 lipid transport, steroid metabolic process 0
BI111416 Echs1 enoyl Coenzyme A hydratase, short chain, 1,
mitochondrial
fatty acid metabolic process, lipid metabolic process 1
AU067703 Sc5d sterol-C5-desaturase homolog lipid biosynthetic process, metabolic process 3
Molecular Transport
AK010399 Snx10 sorting nexin 10 cell communication, protein transport 1
AV371434 Slc5a1 solute carrier family 5, member 1 sodium/glucose cotransporter 2
NM_013612 Slc11a1 solute carrier family 11, member 1 proton-coupled divalent metal ion transporters 3
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increased efficacy for the treatment of cancers in specific patients
with abnormally high NRF2-ARE activation.
The current study also further supports a role of inflammation
in the urethane-induced carcinogenesis model [32], and suggests
the association of multiple inflammatory mediators, particularly
Ptgis and Cxcl1, with Nrf2-dependent tumorigenesis. PTGIS, the
enzyme that synthesizes prostacyclin, is anti-inflammatory in the
lung [33]. Importantly, a 92% reduction in tumor multiplicity was
found in Ptgis-overexpressing mice [33] and prostacyclin analogs
are currently in use for human NSCLC clinical trials in the
National Cancer Institute Lung Cancer Biomarker and Chemo-
prevention Consortium. Heightened Ptgis expression in tumors of
Nrf2
-/- mice suggested that tumor microenvironment suppressed
the normal inflammatory response in these mice. We also found
persistent neutrophilic infiltration and concurrent induction of
Cxcl1 (a neutrophil chemoattractant) in Nrf2
+/+ mice by 22 wk, but
not in Nrf2
-/- mice. Neutrophils are often observed during the
more advanced stages of lung tumor development, specifically
urethane-induced [32], and are thought to be involved in the
production of ROS as indicated by skin carcinogenesis models
[34].
Our transcriptome analysis also identified numerous urethane-
dependent genes in lung tumors of wild-type mice (BALB/cCR),
and the functional categories of these neoplastic genes (e.g., genetic
disorder, cardiovascular system function, cell death, immunolog-
ical disease) were largely not concordant with those of genes
changed at the early-neoplastic stage (e.g., small molecular
biochemistry, nucleic acid metabolism, cell morphology, lipid
metabolism, cell cycle, molecular transport, protein trafficking)
and in uninvolved tissues of tumor-bearing lungs (e.g., small
molecular biochemistry, immune cell trafficking, hematopoiesis,
nucleic acid metabolism, drug metabolism, nerve system function).
These findings indicate distinct biochemical and molecular
changes are occurring in tumor tissues, while transcriptomics in
the pre/early neoplastic stage and in uninvolved tumor microen-
vironments are in general similar. However, transcriptome
changes in cellular growth and proliferation-associated genes were
common throughout all tissues and neoplastic stages. Genes such
as claudin 3 (Cldn3), thymidylate synthetase (Tyms), and thymidine
kinase 1 (Tk1) in these tumors were previously found in a single
injection urethane model (24–42 wk following urethane) in tumors
of A/J mice [35]. In addition, comparison with toll-like receptor 4
(Tlr4) dependent genes in a 2-stage (MCA/BHT) mouse
pulmonary carcinogenesis model [36] identified many genes (e.g.
angiotensin I converting enzyme 2, Ace2; Bcl2-like 14,Bcl2l14;
claudin 2, Cldn2) also to be Nrf2-dependent. Genes changed by
urethane in the early neoplastic stage that also differed in the
MCA-BHT model [36] included amphiregulin (Areg), arginase 1
(Arg1), chemokine receptor 2 (Ccr2), cyclin-dependent kinase
inhibitor 1A (Cdkn1a), epiregulin (Ereg), gap junction protein,
alpha 1 (Gja1), and secreted phosphoprotein 1 (Spp1). Overall from
previous and current tumor analyses using different dosing
regimens, carcinogens, and strains of mice, a panel of common
transcripts (e.g. Arg1, Areg, Ereg, Ccr2, Cdkn1a, Gja1, Ptgis, Spp1) may
provide a useful tool for early diagnosis of lung neoplasm.
In conclusion, our novel results provide evidence that Nrf2
contributes to lung tumorigenesis susceptibility. We propose that
during pulmonary inflammation and injury in the early stages of
tumor development induced by urethane, lung cells in Nrf2
-/- mice
had reduced cell survival factors such as cellular redox and drug
metabolism enzymes and cell maintenance system, relative to
those in Nrf2
+/+ cells (see hypothetical schematic, Figure 7).
Consequently, Nrf2
-/- mice had decreased cytoprotection and
massive death of initiated cells that would normally develop into
adenomas (Figure 7). Nrf2-dependent genes associated in cell cycle
and cell death also affect differential proliferation of these initiated
tumor progenitor cells between Nrf2
+/+ and Nrf2
-/- mice (Figure 7).
Overall, increased susceptibility to urethane-induced pre-neoplas-
tic injury leading to net cell loss due to lack of cell survival signals
in Nrf2
-/- mice is paradoxically beneficial to their tumor
suppression. Results indicate the importance of understanding
the pre-neoplastic pathologic events as well as understanding the
mechanisms through which cancer chemotherapy using supple-
mental antioxidants modulates multi-stage carcinogenesis. In
addition to this unique notion, our transcriptomal analysis
provides new insights into the downstream molecular mechanisms
of Nrf2 in a pulmonary neoplastic microenvironment.
Materials and Methods
Ethics Statement
All animal use was approved by the National Institute of
Environmental Health Sciences Animal Care and Use Committee
under protocol number P03-05 and follows the Helsinki
convention for the use and care of animals.
Animals and carcinogen treatment. Female wild-type
mice (BALB/cCR(Japan)-Nrf2
+/+) and Nrf2 deficient (BALB/
cCR(Japan)-Nrf2
-/-) littermates were generated from a breeding
colony at the National Institute of Environmental Health Sciences
(NIEHS) animal facility. Animals were housed in a virus- and
antigen-free room. Water and mouse chow (modified AIN-76A,
Harlan Teklad, Madison, WI) were provided ad libitum. Mice (4–
6 wk) were injected with urethane (1 mg per g BW in saline;
Sigma, St. Louis, MO) or with vehicle (saline) i.p. weekly for 7 wk.
Mice were sacrificed at 9, 11, 12, or 22 wk after the first injection
by Nembutal overdose (104 g/Kg BW).
Lung fixation, tumor analysis, histopathology and
immunohistopathology. Lung tissues were fixed with
GI Accession
Gene
Symbol Gene Description Major Gene Ontology (GO) Categories
Cluster
(Figure 7A)
Others
BB794642 Mela melanoma antigen RNA-dependent DNA replication, proteolysis, DNA
integration, viral infectious cycle
0
NM_009705 Arg2 arginase type II arginine metabolic process, negative regulation of nitric-
oxide synthase activity
1
*Genes significantly different in lung tumors between Nrf2
+/+ and Nrf2
-/- mice at 22 wk.
doi:10.1371/journal.pone.0026590.t001
Table 1. Contt.
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PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e26590Figure 6. Effect of Nrf2 deletion on gene expression during lung tumorigenesis. (A) Biological function and disorder categories of the Nrf2-
dependent genes (i.e. differentially expressed between Nrf2
+/+ and Nrf2
-/- mice) significantly changed in pre-/early neoplastic stage at 12 wk (top) and
in tumors at 22 wk (bottom) were analysis by Ingenuity Pathway Analysis (IPA). Top-ranked [-log(p)] categories are depicted and compared between
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PLoS ONE | www.plosone.org 10 October 2011 | Volume 6 | Issue 10 | e26590the two tumorigenesis stages. (B) A total of 118 gene transcripts varied significantly (p,0.05) between Nrf2
+/+ and Nrf2
-/- mice 12 wk after urethane
treatment were grouped into 4 expression profiles (set 0–3). Expression level of each transcript was normalized to corresponding Nrf2
+/+ saline
controls and indicated as relative log ratio [log2 (normalized average intensity)]. Genes are listed in Dataset 1 and in Table 1. Sal=saline-treated lung,
UT=urethane-treated lung. (C) Lung tumor genes (n=376) significantly (p,0.05) different between Nrf2
+/+ and Nrf2
-/- mice at 22 wk after urethane
treatment are clustered into 4 expression profile groups (set 0–3). Expression level of each gene was normalized to that of Nrf2
+/+ saline controls and
indicated as relative log ratio [log2 (normalized average intensity)]. Genes are listed in Dataset 2 and in Table 2. Sal=saline-treated lung,
UN=uninvolved tissue, Tum=tumor tissue. (D) Among the Nrf2-dependently changed genes in pre-/early neoplastic stage at 12 wk (n=118) and in
tumors at 22 wk (n=376), Venn diagram analysis identified gene transcripts that were changed at either time point (12 and 22 wk) and/or were
genes in common between the two time points (i.e. 12 genes).
doi:10.1371/journal.pone.0026590.g006
Table 2. Representative lung tumor gene transcripts from a total of 376 that were significantly (p,0.01).
GI Accession
Gene
Symbol Gene Description Major Gene Ontology (GO) Categories
Cluster
(Figure 7C)
Cell cycle, Cell growth and proliferation, Cancer
NM_016904 Cks1b CDC28 protein kinase 1b cell cycle, cell division 0
NM_007631 Ccnd1 cyclin D1 re-entry into mitotic cell cycle, cell cycle 2
NM_013737 Pla2g7 phospholipase A2, group VII inflammatory response, lipid catabolic process 0
NM_009367 Tgfb2 transforming growth factor, beta 2 angiogenesis, axon guidance, blood vessel development 0
NM_028618 Dmkn dermokine cell differentiation 3
NM_011176 St14 suppression of tumorigenicity 14 proteolysis, cell migration 2
NM_027950 Osgin1 oxidative stress induced growth
inhibitor 1
cell differentiation, regulation of cell death 3
Organismal injury and abnormality, Thiol and xenobiotic metabolism, Tumor morphology
NM_010358 Gstm1 glutathione S-transferase, mu 1 glutathione metabolic process 0
NM_013701 Ugt1a1* UDPglucuronosyltransferase 1 family,
polypeptide A1
transferase activity 3
NM_008012 Akr1b8 aldo-keto reductase family 1,
member B8
oxidation reduction 1
NM_030677 Gpx2 glutathione peroxidase 2 response to oxidative stress 0
NM_181415 Atrnl1* attractin like 1 G-protein coupled receptor protein signaling pathway 0
NM_027988 Noxo1 NADPH oxidase organizer 1 superoxide metabolic process, cell communication 0
NM_172442 Dtx4 deltex 4 homolog (Drosophila) Notch signaling pathway 1
NM_010215 Il4i1 interleukin 4 induced 1 aromatic amino acid family metabolic process, regulation of Rab
GTPase activity, oxidation reduction
0
Cell-To-Cell Signaling and Interaction, Tissue Development, Cell morphology
NM_011923 Angptl2 angiopoietin-like 2 signal transduction 2
NM_008176 Cxcl1 chemokine (C-X-C motif) ligand 1 cellular process, immune response, inflammatory response 0
NM_010196 Fga fibrinogen alpha chain signal transduction, blood coagulation, platelet activation, protein
polymerization
0
NM_010576 Itga4 integrin alpha 4 blood vessel remodeling, cell adhesion, cell migration 0
Cardiovascular system development and function, Gene expression
NM_008124 Gjb1 gap junction membrane channel
protein beta 1
cell communication, cell-cell signaling 0
NM_033601 Bcl3 B-cell leukemia/lymphoma 3 B cell and follicular dendritic cell differentiation 0
NM_027286 Ace2 angiotensin I converting enzyme 2 regulation of systemic arterial blood pressure by renin-angiotensin,
proteolysis
3
NM_080457 Muc4 mucin 4 cell adhesion, cell-matrix adhesion 0
NM_009841 Cd14 CD14 antigen immune response, inflammatory response 3
NM_009330 Hnf1b HNF1 homeobox B regulation of transcription, DNA-dependent 3
NM_010807 Marcksl1 MARCKS-like 1 positive regulation of cell proliferation 0
NM_011340 Serpinf1 serine (or cysteine) peptidase inhibitor,
clade F, member 1
negative regulation of angiogenesis, positive regulation of
neurogenesis
0
Carbohydrate and lipid metabolism, Small molecule biochemistry
NM_019395 Fbp1 fructose bisphosphatase 1 glycolysis and gluconeogenesis 0
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buffered formalin (other times) for histopathology and tumor
analysis as described previously [37]. Apoptotic cell death was
determined on lung tissue sections in situ using a TUNEL kit
(Promega, Madison, WI) as described previously [38]. See
Methods S1 for additional details.
BAL cell analyses and myeloperoxidase assay. The right
lung of each mouse was lavaged in situ, four consecutive times with
HBSS (0.5 ml/25 g BW). BAL fluid was then analyzed for total
protein content (a marker of lung permeability change) and
numbers of epithelial (a marker of epithelial cell injury) and
inflammatory cells following published procedures using a
GI Accession
Gene
Symbol Gene Description Major Gene Ontology (GO) Categories
Cluster
(Figure 7C)
NM_008412 Ivl involucrin keratinocyte differentiation, keratinization, 0
NM_022411 Slc13a2 solute carrier family 13 member 2 sodium ion transport (sodium-dependent dicarboxylate
transporter),
1
NM_019588 Plce1 phospholipase C, epsilon 1 activation of MAPK activity, lipid metabolic process 1
NM_25374 Glo1 glyoxalase 1 anti-apoptosis, carbohydrate metabolic process 0
NM_153133 Rdh9 retinol dehydrogenase 9 retinoid metabolic process, steroid metabolic process 0
NM_018737 Ctps2 cytidine 5’-triphosphate synthase 2 pyrimidine nucleotide biosynthetic process, glutamine
metabolic process
0
Others
NM_203320 Cxcl3 chemokine (C-X-C motif) ligand 3 chemotaxis, inflammatory response 3
NM_021564 Fetub* fetuin beta FXR/RXR activation signaling, regulation of the insulin
and hepatocyte growth factor receptors
0
*Genes also significantly different between Nrf2
+/+ and Nrf2
-/- mice at 12 wk after urethane treatment.
varied between Nrf2
+/+ and Nrf2
-/- mice at 22 wk after urethane.
doi:10.1371/journal.pone.0026590.t002
Table 2. Cont.
Figure 7. Proposed role for Nrf2 in urethane-induced lung tumorigenesis. Urethane treatment causes pulmonary inflammation and injury
during the pre-neoplastic stage, which results in overproduction of reactive oxygen species (ROS) and cellular death by necrosis and apoptosis.
Compared to Nrf2
+/+ mice, Nrf2
-/- mice have lowered cell survival factors including cellular redox and drug metabolism enzymes (e.g., glutathione
synthetase, UDP glucuronosyl transferase 1 family) and cell maintenance systems including numerous metabolic enzymes and transport proteins
(e.g., solute carrier family). These mice therefore have heightened cellular destruction factors (e.g., ROS, airway secretion, inflammation), which
overwhelms cellular cytoprotection tools and causes mass death of injured cells including tumor initiated cells during the pre-neoplastic stage. Nrf2
-/-
mice also exhibit dysregulated expressions of many genes involved in cell cycle and death (e.g., CDC28 protein kinases, cyclin D1, cyclin dependent
kinase inhibitor 2C, B-cell leukemia/lymphoma 6, unc-119 homolog) relative to wild type mice during tumorigenesis. Overall, increased susceptibility
to acute injury due to lack of survival signals leading to net cell loss is beneficial to Nrf2
-/- mice for their tumor suppression.
doi:10.1371/journal.pone.0026590.g007
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McGaw Park, IL) [36]. Due to cellular lysis in BAL which
prohibited neutrophil enumeration, neutrophil abundance in
BAL was quantified through measurement of neutrophil
myeloperoxidase (MPO) using a colorimetric analysis kit
(Cytostore, Canada) which assessed conversion of hydrogen
peroxide to oxygen radicals by MPO. Cell viability and
cytotoxicity were determined by the amount of released LDH in
BAL aliquots (50 ml) using a colorimetric assay (Sigma-Aldrich, St.
Louis, MO).
Tissue protein isolation. Tumors (involved regions) were
micro-dissected from lungs and remaining uninvolved tissue (UN)
was used as a control in urethane-treated lungs at 22 wk. Snap
frozen tumor, UN, or whole lungs (saline-treated controls and
urethane-treated lungs at 12 wk) were homogenized (n=3/group)
in RIPA buffer. Nuclear proteins were isolated from pulverized
lung samples following procedures described elsewhere [39].
Proteins were quantified and stored in aliquots at 270uC.
Electrophoretic mobility shift assay (EMSA). Nuclear
DNA binding activity of Nrf2 was determined by EMSA
analyses of nuclear protein aliquots (5 mg) on 3610
4 cpm [c
32P]
ATP end-labeled ARE consensus sequence following procedures
described previously [40]. Specific binding activity for Nrf2 and
small Maf protein was determined by pre-incubation of nuclear
proteins with anti-Nrf2 (sc-722x, Santa Cruz Biotechnology, Santa
Cruz, CA) and anti-small Maf (F/K/G) antibody (sc-22831x,
Santa Cruz ), respectively, followed by EMSA.
Immunoblot analyses and GSH measurement. Lung
total (30–50 mg) or nuclear (10 mg) proteins were separated on
appropriate percentage Tris-HCl SDS-PAGE gels (Bio-Rad,
Hercules, CA) and analyzed by routine immunoblotting using
specific antibodies against Ki67 (Abcam Inc., Cambridge, MA),
Nrf2 (Santa Cruz), lamin B1 (sc-20682, Santa Cruz), or actin (sc-
1615, Santa Cruz). Representative protein blot images from
multiple analyses were scanned by a Bio-Rad Gel Doc system
(Hercules, CA). Total GSH level was determined in lung RIPA
homogenates by a colorimetric method following manufacturer
instructions (Northwest Life Science Specialties, LLC, Vancouver,
WA).
Affymetrix cDNA Microarray Analysis. Total RNA was
isolated from homogenates of total lung, UN or TU tissues (n=3/
group) using Qiagen RNeasy Mini kits (Qiagen Inc., Valencia,
CA). Microarray processing was done by the NIEHS Microarray
Core Facility as described previously [36] with Affymetrix mouse
genome 430_2.0 microarrays using Affymetrix reagents and
protocols (Santa Clara, CA). GeneSpring Expression Analysis
(Agilent Technologies, Inc., Santa Clara, CA) was used for
statistical analyses and characterization of data and Ingenuity
Pathway Analysis (IPA) software (www.ingenuity.com, Ingenuity
Systems, Inc., Redwood City, CA) identified potentially signi-
ficant functional connections and mechanistic pathways.
Characterization of the microarray data is described in Methods
S1.
Quantitative reverse transcriptase-polymerase chain
reaction (qRT-PCR). An aliquot (1 mg) of total lung RNA
was reverse transcribed as previously published [40] and gene
specific primers used in quantitative RT-PCR reactions, similar to
previous publications [33]. For additional details, see Methods S1.
Statistical analysis of non-microarray data. Data were
expressed as group mean6standard deviation. Two-way ANOVA
was used to evaluate effects of treatment (vehicle, urethane)
between two genotypes (Nrf2
+/+, Nrf2
-/-). The Student-Newman-
Keuls test was used for a posteriori comparisons of means (p,0.05).
All statistical analyses were performed using the SigmaStat 3.0
software program (SPSS Science Inc., Chicago, IL).
Supporting Information
Figure S1 Airway cytotoxicity and secretion in pre-
neoplastic stage. Giemsa-stained cytocentrifuge slides of
bronchoalveolar lavage (BAL) fluid show increased BAL cell
populations and greater cell clustering and lysis caused by
urethane in Nrf2
-/- than in Nrf2
+/+ mice before tumor development
at 9 wk (inset: higher magnification of BAL cells). Enhanced
airway secretion (black arrow heads) and epithelial mucous
production (black arrows) as indicated by AB/PAS-stained
bronchial airway sections at 9 wk was consistent with clustering
of the BAL cells in Nrf2
-/- mice (inset: lower magnification of
proximal airway and airspace). At 11 wk, clustering was resolved
but greater cell lysis and cell debris in Nrf2
-/- mice were
accompanied by appearance of macrophages with phagocytosis-
like features (red arrows) Insets present higher magnification of
phagocytic macrophages. Representative slides showing interme-
diate magnitude of pathology for each treatment group are
presented. AV, alveoli; BR, bronchi; PA, pulmonary artery. Bars
indicate 100 mm.
(TIF)
Figure S2 Top functional networks of significantly
changed gene transcripts in lung tumors of Nrf2
+/+ mice
at 22 wk. Ingenuity Pathway Analysis (IPA) generated essential
functional networks of the genes significantly ($2-fold, n=3461)
changed in Nrf2
+/+ tumors. Highest association score (40) was for
the genetic disorder-skeletal and muscular disorders- developmen-
tal disorder network (A) where the genes such as coiled-coil
domain containing 85A, (Ccdc85a), dystrophin, muscular dystrophy
(Dmd), and fyn proto-oncogene (Fyn) were mapped. Many genes
(e.g., CCAAT/enhancer binding protein (C/EBP) alpha, Cebpa;
lymphotoxin B, Ltb) were identified for cellular development-
cellular growth and proliferation-hematological system develop-
ment and function-hematopoiesis networks (B and C, Scores 34
and 33, respectively) and others related in cell cycle- cellular
movement-cancer network (D, score 33, e.g., p21, Cdkn1a; cell
division cycle 20, Cdc20) or in amino acid metabolism-molecular
transport-small molecular biochemistry (E, Score 33, e.g., platelet
derived growth factor receptor, beta polypeptide Pdgfrb; platelet-
activating factor acetylhydrolase, isoform 1b, subunit 3, Pafah1b3)
were also closely associated during tumorigenesis. (.ppt).
(PPT)
Figure S3 Top functional networks of Nrf2-dependent
genes changed during urethane-induced tumorigenesis.
(A) Ingenuity Pathway Analysis (IPA) generated a key network
(Score 54) of cell-to-cell signaling and interaction-connective tissue
development and function-ophthalmic disease with Nrf2-depen-
dently regulated genes in pre-/early-neoplastic microenvironment
(12 wk), in which genes encoding matrix metalloproteinase 2
(Mmp2) and D site albumin promoter binding protein (Dbp) were
mapped as core molecules. (B) Nrf2-dependent lung tumor genes
were highly associated in the networks of cell cycle-cancer-
connective tissue development and function (Score 43, e.g., cyclin
D1, Ccnd1; E2F transcription factor 3, E2f3), cell-to-cell signaling
and interaction-tissue development-cell function (Score 38, e.g.,
chemokine (C-X-C motif) ligand 1, Cxcl1; integrin alpha 4, Itga4),
and tumor morphology-cancer-dermatological disease and condi-
tions (Score 38, e.g., G protein-coupled 56, Gpr56; glutathione-S-
transferase, alpha 3, Gsta3) as generated by IPA. (C) Nrf2-
dependently modulated genes in common (n=21 genes) in early-
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were functionally associated in cancer-cell cycle-cell death network
(Score 23). They included genes encoding CD34, UGT1a1, fetuin
beta (Fetub), G protein-coupled receptor 137B (Gpr137b), ATP
binding cassette, subfamily C, member 4 (Abcc4), phosphogluco-
nate dehydrogenase (Pgd), etc. (.ppt).
(PPT)
Figure S4 Confirmation of microarray transcript pro-
files. (A) Expression of selected antioxidant/defense gene
transcripts that were found by microarray analysis to be
significantly increased or decreased by urethane in tumor tissues
(22 wk): aldo-keto reductase family 1, member B8 (Akr1b8),
aldehyde oxidase 3 (Aox3), peroxiredoxin 1 (Prdx1), glutathione
peroxidase 2 (Gpx2), glutathione-S-transferase-m (Gstm), and
aldehyde dehydrogenase 1 family, member A1 (Aldh1a1). Relative
suppression of these cytoprotective genes was evident in Nrf2
-/-
mice. Total glutathione (GSH) was determined in whole lung
homogenates using a colorimetric kinetic analysis to support the
differential induction of key GSH synthesis enzymes (e.g.,
glutathione synthetase, Gss; glutamate-cystein ligase, catalytic
subunit, Gclc; glucose-6-phosphate dehydrogenase X-linked,
G6pdx) between Nrf2
+/+ and Nrf2
-/- mice during the tumorigenesis.
Mean6SEM are presented (n=3/group). *, p,0.05 vs. genotype-
matched saline control mice. +,p ,0.05 vs. treatment-matched
Nrf2
+/+ mice. Expression of selected lung genes significantly varied
between Nrf2
+/+ and Nrf2
-/- mice at 12 wk (B) and at 22 wk (C)
were determined by qRT-PCR. All qRT-PCR graphs depicted
fold differences relative to Nrf2
+/+ saline level of 18s-normalized
data. All qRT-PCR data are represented as group mean6SEM
(n=3/group).
(TIFF)
Table S1 Representative lung genes significantly
changed by urethane at 12 wk in Nrf2
+/+ mice
(n=6519, p,0.05).
(DOC)
Table S2 Top functional networks and involved genes
significantly (p,0.05) changed in uninvolved tissues and
in tumors of Nrf2
+/+ mice at 22 wk.
(DOC)
Dataset S1 12 wk Saline vs. Urethane Nrf2-WT vs. Nrf2-
KO.
(XLS)
Dataset S2 Genes differentially changed between Nrf2-
WT and Nrf2-KO mice by urethane in tumors at 22 wk
(n=376).
(XLS)
Dataset S3 Canonical pathways for 376 tumor genes
significantly varied between Nrf2+/+ and Nrf2-/- mice
at 22 wk.
(XLS)
Methods S1
(DOC)
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